AAAAAA
Results:
1-17
|
Results: 17
Authors:
Mushipe, MT
Revell, PA
Shelton, JC
Citation: Mt. Mushipe et al., Cancellous bone repair using bovine trabecular bone matrix particulates, BIOMATERIAL, 23(2), 2002, pp. 365-370
Authors:
Saeed, S
Revell, PA
Citation: S. Saeed et Pa. Revell, Production and distribution of interleukin 15 and its receptors (IL-15R alpha and IL-R2 beta) in the implant interface tissues obtained during revision of failed total joint replacement, INT J EXP P, 82(3), 2001, pp. 201-209
Authors:
Hercus, B
Revell, PA
Citation: B. Hercus et Pa. Revell, Phenotypic characteristics of T lymphocytes in the interfacial tissue of aseptically loosened prosthetic joints, J MAT S-M M, 12(10-12), 2001, pp. 1063-1067
Authors:
Calder, JDF
Pearse, MF
Revell, PA
Citation: Jdf. Calder et al., The extent of osteocyte death in the proximal femur of patients with osteonecrosis of the femoral head, J BONE-BR V, 83B(3), 2001, pp. 419-422
Authors:
Dube, PH
Revell, PA
Chaplin, DD
Lorenz, RG
Miller, VL
Citation: Ph. Dube et al., A role for IL-1 alpha in inducing pathologic inflammation during bacterialinfection, P NAS US, 98(19), 2001, pp. 10880-10885
Authors:
Clarke, SA
Revell, PA
Citation: Sa. Clarke et Pa. Revell, Integrin expression at the bone/biomaterial interface, J BIOMED MR, 57(1), 2001, pp. 84-91
Authors:
Bainbridge, JA
Revell, PA
Al-Saffar, N
Citation: Ja. Bainbridge et al., Costimulatory molecule expression following exposure to orthopaedic implants wear debris, J BIOMED MR, 54(3), 2001, pp. 328-334
Authors:
Revell, PA
Miller, VL
Citation: Pa. Revell et Vl. Miller, A chromosomally encoded regulator is required for expression of the Yersinia enterocolitica inv gene and for virulence, MOL MICROB, 35(3), 2000, pp. 677-685
Authors:
Al-Saffar, N
Revell, PA
Citation: N. Al-saffar et Pa. Revell, Differential expression of transforming growth factor-alpha and macrophagecolony-stimulating factor/colony-stimulating factor-1R (c-fms) by multinucleated giant cells involved in pathological bone resorption at the site of orthopaedic implants, J ORTHOP R, 18(5), 2000, pp. 800-807
Authors:
Al-Saffar, N
Revell, PA
Citation: N. Al-saffar et Pa. Revell, Pathology of the bone-implant interfaces, J LONG-TE E, 9(4), 1999, pp. 319-347
Authors:
Thompson, JI
Gregson, PJ
Revell, PA
Citation: Ji. Thompson et al., Analysis of push-out test data based on interfacial fracture energy, J MAT S-M M, 10(12), 1999, pp. 863-868
Authors:
Zhang, XS
Revell, PA
Citation: Xs. Zhang et Pa. Revell, In situ localization of apoptotic changes in the interface membrane of aseptically loosened orthopaedic implants, J MAT S-M M, 10(12), 1999, pp. 879-883
Authors:
Hing, KA
Best, SM
Tanner, KE
Bonfield, W
Revell, PA
Citation: Ka. Hing et al., Quantification of bone ingrowth within bone-derived porous hydroxyapatite implants of varying density, J MAT S-M M, 10(10-11), 1999, pp. 663-670
Authors:
Zhang, XS
Revell, PA
Evans, SL
Tuke, MA
Gregson, PJ
Citation: Xs. Zhang et al., In vivo biocompatibility and mechanical study of novel bone-bioactive materials for prosthetic implantation, J BIOMED MR, 46(2), 1999, pp. 279-286
Authors:
Blades, MC
Moore, DP
Revell, PA
Hill, R
Citation: Mc. Blades et al., In vivo skeletal response and biomechanical assessment of two novel polyalkenoate cements following femoral implantation in the female New Zealand White rabbit, J MAT S-M M, 9(12), 1998, pp. 701-706
Authors:
Revell, PA
Jellie, SE
Citation: Pa. Revell et Se. Jellie, Interleukin 15 production by macrophages in the implant interface membraneof aseptically loosened joint replacements, J MAT S-M M, 9(12), 1998, pp. 727-730
Authors:
Al-Saffar, N
Iwaki, H
Revell, PA
Citation: N. Al-saffar et al., Direct activation of mast cells by prosthetic biomaterial particles, J MAT S-M M, 9(12), 1998, pp. 849-853
Risultati:
1-17
|